Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of MEDI3414 H1N1 Vaccine in Adults
NCT00945893Phase 4Completed
- Sponsor
- MedImmune
- Start
- Aug 2009
- Primary completion
- Sep 2009
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of MEDI3414 in influenza A/H1N1 (H1N1), sponsored by MedImmune. Started Aug 2009; status: completed.
02
Drugs
MEDI3414
03
Conditions
influenza A/H1N1 (H1N1)
Beyond the preview
Go deeper on NCT00945893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00945893.